Revospirone

Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed.^[1] It acts as a selective 5-HT_1A receptor partial agonist.^[2] Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite.^[2] As a result, it also acts as an α₂-adrenergic receptor antagonist to an extent.^[2]

Revospirone

Clinical data
ATC code	none
Identifiers
IUPAC name 1,1-dioxo-2-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]-1,2-benzothiazol-3-one
CAS Number	95847-87-3
PubChem CID	72024
ChemSpider	65018
UNII	6X8764TW2J
CompTox Dashboard (EPA)	DTXSID10241982
Chemical and physical data
Formula	C18H21N5O3S
Molar mass	387.46 g·mol−1